IL308068A - Method of titrating dose of psychedelics - Google Patents
Method of titrating dose of psychedelicsInfo
- Publication number
- IL308068A IL308068A IL308068A IL30806823A IL308068A IL 308068 A IL308068 A IL 308068A IL 308068 A IL308068 A IL 308068A IL 30806823 A IL30806823 A IL 30806823A IL 308068 A IL308068 A IL 308068A
- Authority
- IL
- Israel
- Prior art keywords
- psychedelics
- titrating
- dose
- titrating dose
- Prior art date
Links
- 230000001337 psychedelic effect Effects 0.000 title 1
- 239000003196 psychodysleptic agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measurement Of Radiation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163183579P | 2021-05-03 | 2021-05-03 | |
PCT/US2022/027179 WO2022235529A1 (en) | 2021-05-03 | 2022-05-01 | Method of titrating dose of psychedelics |
Publications (1)
Publication Number | Publication Date |
---|---|
IL308068A true IL308068A (en) | 2023-12-01 |
Family
ID=83932279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL308068A IL308068A (en) | 2021-05-03 | 2022-05-01 | Method of titrating dose of psychedelics |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP4333979A1 (en) |
JP (1) | JP2024517194A (en) |
AU (1) | AU2022268891A1 (en) |
CA (1) | CA3216939A1 (en) |
IL (1) | IL308068A (en) |
TW (1) | TW202245767A (en) |
WO (1) | WO2022235529A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2023014620A (en) | 2021-06-09 | 2024-01-30 | Atai Therapeutics Inc | Novel prodrugs and conjugates of dimethyltryptamine. |
JP2024531437A (en) | 2021-08-20 | 2024-08-29 | ファーマラ バイオテック インコーポレイテッド | Compositions Comprising Non-Racemic Mixtures of (R)-3,4-Methylenedioxymethamphetamine and (S)-3,4-Methylenedioxymethamphetamine or (R)N-Methyl-1,3-Benzodioxolylbutanamine and (S)N-Methyl-1,3-Benzodioxolylbutanamine, and Uses Thereof |
AU2022425541A1 (en) | 2021-12-30 | 2024-06-06 | Atai Therapeutics, Inc. | Dimethyltryptamine analogues as nitric oxide delivery drugs |
US20230202978A1 (en) | 2022-03-04 | 2023-06-29 | Reset Pharmaceuticals, Inc. | Co-crystal or salt |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11723894B2 (en) * | 2017-10-26 | 2023-08-15 | Terran Biosciences, Inc. | Combination product for the treatment of neurological and/or psychiatric disorders |
CA3146050A1 (en) * | 2019-07-04 | 2021-01-07 | Sw Holdings, Inc. | Metered dosing compositions and methods of use of psychedelic compounds |
-
2022
- 2022-05-01 CA CA3216939A patent/CA3216939A1/en active Pending
- 2022-05-01 WO PCT/US2022/027179 patent/WO2022235529A1/en active Application Filing
- 2022-05-01 EP EP22799340.9A patent/EP4333979A1/en active Pending
- 2022-05-01 AU AU2022268891A patent/AU2022268891A1/en active Pending
- 2022-05-01 JP JP2023566881A patent/JP2024517194A/en active Pending
- 2022-05-01 IL IL308068A patent/IL308068A/en unknown
- 2022-05-03 TW TW111116665A patent/TW202245767A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022235529A1 (en) | 2022-11-10 |
AU2022268891A1 (en) | 2023-11-09 |
JP2024517194A (en) | 2024-04-19 |
EP4333979A1 (en) | 2024-03-13 |
CA3216939A1 (en) | 2022-11-10 |
TW202245767A (en) | 2022-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL308068A (en) | Method of titrating dose of psychedelics | |
IL292754A (en) | Method of synthesis | |
GB2584946B (en) | Method of selecting ions | |
GB2590601B (en) | Method of mass spectrometry | |
GB201804594D0 (en) | Bonegraft substituteand method of manufacture | |
IL287210A (en) | Method of treating tumours | |
GB201802839D0 (en) | Method of manufacture | |
SG10202003054XA (en) | Manufacturing method of chips | |
EP3980796C0 (en) | Method of cyclic coulometry | |
IL289811A (en) | Method of treating cancer | |
SG11202113371VA (en) | Method of synthesizing chemical compounds | |
GB2553390B (en) | Method of manufacture | |
GB201900971D0 (en) | Insole apparatus and method of manufacture thereof | |
IL287250A (en) | Method of treatment | |
IL280064A (en) | Method of making an aerosol forming substrate | |
GB202015840D0 (en) | Method of forming an electrode | |
SG11202105877YA (en) | Method of treatment | |
GB201911056D0 (en) | Treatment of ADD/ADHD | |
GB2561372B (en) | Method of producing ions | |
GB2602912B (en) | Method of packaging | |
GB201704816D0 (en) | Method of manufacture | |
GB201905379D0 (en) | Method of epoxidation | |
ZA201903823B (en) | Method of encapsulation | |
GB201906748D0 (en) | Method of formulation | |
GB202106258D0 (en) | Method of formulation |